Latest news

07.06.2017

Coll2-1 in viscosupplementation: results form Epikart study


Artialis' biomarker Coll2-1 and viscosupplementation of hyaluronic acid: results from EPIKART, a Pilot Prospective Comparative Randomized Double Blind Trial.

Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial.

PubMed